this is being tested in the ongoing HYPERION trial. "We also await data of the use of sotatercept in post-capillary pulmonary hypertension ([WHO] group 2). If the CADENCE study is positive ...

Each trial has unique stipulations, and its time can be extended by following the rules closely. Each trial takes place in three separate chambers where Clive must face three different waves of ...